Chesterford Research Park company’s strategy is described as ‘enormously promising’.
CEO Pascal Soriot says he is ‘quite confident’ potential coronavirus vaccine will work - but admits it's a race to prove it.
The money will support SMEs looking to access expertise or test products.
The pharma company is carrying out groundbreaking work to fight Alzheimer’s.
Its reagents bind to the SARS-CoV-2 viral antigen.
The Pampisford company will help identify suitable antibodies.
The Cambridge company says the trials are a validation of its approach.
The company has joined the platform, which is aimed at accelerating research and trials into potential therapies.
The work reveals potential targets for tackling the high transmission of the coronavirus.
They will adopt a non-profit approach during pandemic.
